{
    "clinical_study": {
        "@rank": "23405", 
        "acronym": "EZI", 
        "arm_group": [
            {
                "arm_group_label": "Electronic Cigarette", 
                "arm_group_type": "Experimental", 
                "description": "Participants received the electronic cigarette for use instead of cigarettes when in the presence of their child(ren) for up to 8 weeks."
            }, 
            {
                "arm_group_label": "Dissolvable Tobacco Lozenge", 
                "arm_group_type": "Experimental", 
                "description": "Participants received the dissolvable tobacco lozenge for use instead of cigarettes when in the presence of their child(ren) for up to 8 weeks."
            }, 
            {
                "arm_group_label": "Dissolvable Nicotine Lozenge (Nicorette)", 
                "arm_group_type": "Experimental", 
                "description": "Participants received the dissolvable nicotine lozenge (Nicorette) for use instead of cigarettes when in the presence of their child(ren) for up to 8 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "The overall aim of the current study is to determine if the use of nicotine containing\n      products by caregivers who smoke and who are not interested in quitting, is effective in\n      reducing children's secondhand smoke exposure."
        }, 
        "brief_title": "Preliminary Investigation of Novel Methods to Reduce Children's Secondhand Smoke Exposure", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Secondhand Smoke", 
        "condition_browse": {
            "mesh_term": "Smoking"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria: In order to be included in the study, participants must:\n\n          1. be the primary caregiver(defined as a person who spends the most time with the child\n             and spends a minimum of 4 hours per day in the presence of the child) of a child\n             between the ages of 3-11 (if caregiver has more > 1 child between 3-11 years, we will\n             include the youngest)\n\n          2. smoke at least 10 cigarettes per day for the past year\n\n          3. indicate that they smoke around their child or in the car or home at least one time\n             per week]\n\n          4. have no intention of quitting smoking in the next 12-weeks\n\n          5. aged 18-65 years\n\n          6. be fluent in English\n\n          7. have no recent history of cardiovascular distress that may contraindicate medicinal\n             nicotine lozenge use (heart attack in the past year, arrhythmia, uncontrolled\n             hypertension)\n\n          8. not currently pregnant, planning to become pregnant, or breastfeeding\n\n          9. do not use non-cigarette tobacco (cigars, chewing tobacco)\n\n         10. have no prior use of any potential reduced exposure product\n\n         11. have no major psychiatric impairment, including psychosis, suicidality, and/or any\n             current alcohol/drug abuse or dependence\n\n        Exclusion Criteria:\n\n          -  Does not meet all of the requirements of inclusion criteria"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "89", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01935713", 
            "org_study_id": "EZ Study"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dissolvable Nicotine Lozenge (Nicorette)", 
                "description": "Participants were given the choice of 2mg or 4mg lozenges depending on how many cigarettes per day they reported to smoke.", 
                "intervention_name": "Nicotine polacrilex", 
                "intervention_type": "Drug", 
                "other_name": "Nicorette"
            }, 
            {
                "arm_group_label": "Electronic Cigarette", 
                "description": "Participants were given an e-cigarette starter kit, charging case, and cartridges in either 12mg or 16 mg nicotine, depending on their current amount of cigarettes smoked per day.", 
                "intervention_name": "Electronic Cigarette", 
                "intervention_type": "Drug", 
                "other_name": "Smoke Tip"
            }, 
            {
                "arm_group_label": "Dissolvable Tobacco Lozenge", 
                "description": "Participants were given Ariva (light to moderate smokers) or Stonewall (heavier smokers, >2 packs per day).", 
                "intervention_name": "Dissolvable Tobacco Lozenge", 
                "intervention_type": "Drug", 
                "other_name": "Ariva, Stonewall"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nicotine", 
                "Nicotine polacrilex"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Oklahoma City", 
                    "country": "United States", 
                    "state": "Oklahoma", 
                    "zip": "73104"
                }, 
                "name": "The Children's Hospital at OU Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Novel Methods to Reduce Children's Secondhand Smoke Exposure I", 
        "overall_official": {
            "affiliation": "OTRC, OU Children's Hospital Dept. of Pediatrics, OU Cancer Center", 
            "last_name": "Theodore Wagener, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Child salivary cotinine will be measured to assess the level of secondhand smoke exposure. We will measure the change throughout the study.", 
            "measure": "Change in child salivary cotinine", 
            "safety_issue": "No", 
            "time_frame": "2, 4, 8, and 12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01935713"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "We will collect both parent and child spirometry data and compare changes.", 
            "measure": "Change in Parent and Child Lung Function", 
            "safety_issue": "No", 
            "time_frame": "2, 4, 8, and 12 weeks"
        }, 
        "source": "University of Oklahoma", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Oklahoma", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}